COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 755: Articles 7541-7550  | Next

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
Yuan, M., Wang, Y., Lv, H., Wilson, I. A., Wu, N. C.
10.1101/2022.05.17.492220 — Posted: 2022-05-18
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression
Arshad, N., Laurent-Rolle, M., Ahmed, W. S., Hsu, J. C.-C., Mitchell, S. M., Pawlak, J., Sengupta, D., Biswas, K. H., Cresswell, P.
10.1101/2022.05.17.492198 — Posted: 2022-05-17
Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction
Mollentze, N., Keen, D., Munkhbayar, U., Biek, R., Streicker, D. G.
10.1101/2022.05.16.492068 — Posted: 2022-05-17
United States' political climates and the spread of SARS-2-COVID-19 during 2020
Pratto, F., Cortopassi, A., Marrouch, N.
10.1101/2022.05.16.22275162 — Posted: 2022-05-17
Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Batra, R., Wahlen, W., Alvarez-Mulett, S., Hoffman, K., Simmons, W., Harrington, J., Chetnik, K., Buyukozkan, M., Benedetti, E., Choi, M. E., Suhre, K., Schmidt, F., Schenck, E., Choi, A. M. K., Cho, S. J., Krumsiek, J.
10.1101/2022.05.16.22274587 — Posted: 2022-05-17
Severity of dental caries in New York City children receiving school-based prevention and the role of SARS-Cov-2: Results from the CariedAway pragmatic trial
Ruff, R. R., Barry-Godin, T., Whittemore, R., Small, T. M., Santiago-Galvin, N., Sharma, P.
10.1101/2022.05.16.22275165 — Posted: 2022-05-17
A hybrid approach to predict COVID-19 cases using neural networks and inverse problem
Paul, S., Lorin, E.
10.1101/2022.05.17.22275205 — Posted: 2022-05-17
Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial
Shah, M. R., Fatima, S., Khan, S. N., Ullah, S., Himani, G., Wan, K. H., Lin, T. P. H., Lau, J. Y., Liu, Q., Lam, D. S. C.
10.1101/2022.05.16.22275074 — Posted: 2022-05-17
Antibody response to SARS-CoV2 among COVID-19 confirmed cases, and correlates with neutralizing assay in a subgroup of patients in Delhi National Capital Region, India
Misra, P., Kant, S., Guleria, R., Rai, S., Jaiswal, A., Mandal, S., Medigeshi, G. R., Ahmad, M., Rahman, A., Sangral, M., Yadav, K., Bairwa, M., Haldar, P., Kumar, P.
10.1101/2022.05.17.22275193 — Posted: 2022-05-17
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination.
Kenny, G., Negi, R., O'Reilly, S., Garcia Leon, A. A., Alalwan, D., Gaillard, C. M., Saini, G., Inzitari, R., Feeney, E., Cotter, A. G., de Barra, E., Sadlier, C., Crispie, F., Gautier, V., Mallon, P., All Ireland Infectious Diseases Cohort Study
10.1101/2022.05.16.22275163 — Posted: 2022-05-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).